| |
| |
|
| Insider
Information: |
Cheng Andrew |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
589,447 |
|
|
Indirect Shares
|
17,488 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
606,935 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Akero Therapeutics, Inc. |
AKRO |
|
2024-03-13 |
589,447 |
|
0 |
Premium* |
|
|
Vera Therapeutics, Inc. |
VERA |
Director |
2021-05-18 |
0 |
2021-05-18 |
17,488 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2024-03-13 |
4 |
S |
$28.33 |
$55,782 |
D/D |
(1,969) |
589,447 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2024-03-04 |
4 |
AS |
$31.40 |
$2,465,063 |
D/D |
(75,000) |
591,416 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2024-03-04 |
4 |
OE |
$16.00 |
$1,288,062 |
D/D |
75,000 |
666,416 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2024-01-02 |
4 |
OE |
$0.62 |
$24,600 |
D/D |
40,000 |
590,911 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-12-14 |
4 |
S |
$20.76 |
$33,797 |
D/D |
(1,628) |
550,911 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-12-11 |
4 |
AS |
$20.02 |
$148,273 |
D/D |
(7,405) |
552,539 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-12-11 |
4 |
OE |
$6.36 |
$47,096 |
D/D |
7,405 |
559,944 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-12-08 |
4 |
OE |
$6.36 |
$81,872 |
D/D |
12,873 |
473,871 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-12-08 |
4 |
AS |
$20.01 |
$257,571 |
D/D |
(12,873) |
460,998 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
91,541 |
552,539 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-12-07 |
4 |
AS |
$20.02 |
$134,125 |
D/D |
(6,700) |
460,998 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-12-07 |
4 |
OE |
$6.36 |
$42,612 |
D/D |
6,700 |
467,698 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-10-02 |
4 |
AS |
$46.06 |
$1,197,827 |
D/D |
(25,000) |
460,998 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-10-02 |
4 |
OE |
$6.36 |
$159,000 |
D/D |
25,000 |
485,998 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-09-13 |
4 |
AS |
$50.34 |
$84,672 |
D/D |
(1,682) |
460,998 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-09-01 |
4 |
AS |
$49.77 |
$1,244,248 |
D/D |
(25,000) |
462,680 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-09-01 |
4 |
OE |
$6.36 |
$159,000 |
D/D |
25,000 |
487,680 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-08-30 |
4 |
OE |
$0.62 |
$9,225 |
D/D |
15,000 |
462,680 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-08-01 |
4 |
OE |
$6.36 |
$159,000 |
D/D |
25,000 |
472,680 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-08-01 |
4 |
AS |
$42.85 |
$1,078,867 |
D/D |
(25,000) |
447,680 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-07-03 |
4 |
AS |
$44.66 |
$1,122,041 |
D/D |
(25,000) |
447,680 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-07-03 |
4 |
OE |
$6.36 |
$159,000 |
D/D |
25,000 |
472,680 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-06-27 |
4 |
OE |
$0.62 |
$24,600 |
D/D |
40,000 |
447,680 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2023-06-13 |
4 |
AS |
$55.16 |
$88,973 |
D/D |
(1,613) |
407,680 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2023-06-01 |
4 |
AS |
$44.18 |
$1,127,430 |
D/D |
(25,000) |
409,293 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
